Perioperative management of anticoagulated patients having cataract surgery National audit of current practice of members of the Royal College of Ophthalmologists

被引：17

作者：

Batra, Ruchika ^{[1
]}

Maino, Anna ^{[1
]}

Ch'ng, Sun W. ^{[1
]}

Marsh, Ian B. ^{[1
]}

机构：

[1] Aintree Univ Hosp NHS Fdn Trust, Dept Ophthalmol, Liverpool L9 7AL, Merseyside, England

来源：

JOURNAL OF CATARACT AND REFRACTIVE SURGERY | 2009年 / 35卷 / 10期

关键词：

ATRIAL-FIBRILLATION; WARFARIN THERAPY; ANTIPLATELET;

D O I：

10.1016/j.jcrs.2009.05.042

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

An 11-item questionnaire was mailed to 891 consultant members of the Royal College of Ophthalmologists (RCOphth) to audit compliance with RCOphth guidelines for perioperative management of anticoagulated patients having cataract surgery. Four hundred ninety-nine questionnaires were analyzed. The results showed that 29.5% of respondents adhered to all aspects of RCOphth guidelines; that is, they checked the international normalized ratio (INR) preoperatively, continued warfarin, operated within the desired therapeutic INR range for the condition that warfarin was being used to treat (as set by the treating physician), and considered sub-Tenon or topical anesthesia in anticoagulated patients.

引用

页码：1815 / 1820

页数：6

共 14 条

[1] Phacoemulsification of cataract in patients receiving coumadin theraphy: Ocular and hematologic risk assessment [J].

Barequet, Irina S. ;

Sachs, Dan ;

Priel, Ayelet ;

Wasserzug, Yael ;

Martinowitz, Uri ;

Moisseiev, Joseph ;

Salomon, Ophira .

AMERICAN JOURNAL OF OPHTHALMOLOGY, 2007, 144 (05) :719-723

[2] The Cataract National Dataset electronic multicentre audit of 55 567 operations: antiplatelet and anticoagulant medications [J].

Benzimra, J. D. ;

Johnston, R. L. ;

Jaycock, P. ;

Galloway, P. H. ;

Lambert, G. ;

Chung, A. K. K. ;

Eke, T. ;

Sparrow, J. M. .

EYE, 2009, 23 (01) :10-16

[3] OPTIMAL ORAL ANTICOAGULANT-THERAPY IN PATIENTS WITH MECHANICAL HEART-VALVES [J].

CANNEGIETER, SC ;

ROSENDAAL, FR ;

WINTZEN, AR ;

VANDERMEER, FJM ;

VANDENBROUCKE, JP ;

BRIET, E .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (01) :11-17

[4]

DUNN M, 1989, CHEST, V95, pS118, DOI 10.1378/chest.95.2.118S

[5] OCULAR SURGERY ON PATIENTS RECEIVING LONG-TERM WARFARIN THERAPY [J].

GAINEY, SP ;

ROBERTSON, DM ;

FAY, W ;

ILSTRUP, D .

AMERICAN JOURNAL OF OPHTHALMOLOGY, 1989, 108 (02) :142-146

[6] HYPERCOAGULABLE STATE AND THROMBOEMBOLISM FOLLOWING WARFARIN WITHDRAWAL IN POST-MYOCARDIAL-INFARCTION PATIENTS [J].

GRIP, L ;

BLOMBACK, M ;

SCHULMAN, S .

EUROPEAN HEART JOURNAL, 1991, 12 (11) :1225-1233

[7] Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery [J].

Katz, J ;

Feldman, MA ;

Bass, EB ;

Lubomski, LH ;

Tielsch, JM ;

Petty, BG ;

Fleisher, LA ;

Schein, OD .

OPHTHALMOLOGY, 2003, 110 (09) :1784-1788

[8]

KOUDSTAAL PJ, 1993, LANCET, V342, P1255

[9] MANAGEMENT OF THE ANTICOAGULATED PATIENT FOR OPHTHALMIC SURGERY [J].

MCCORMACK, P ;

SIMCOCK, PR ;

TULLO, AB .

EYE, 1993, 7 :749-750

[10] ANTICOAGULANT-THERAPY AND CATARACT-SURGERY [J].

MOLL, AC ;

VANRIJ, G ;

VANDERLOOS, TLJM .

DOCUMENTA OPHTHALMOLOGICA, 1989, 72 (3-4) :367-373

← 1 2 →